BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25175799)

  • 1. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
    Garcia MF; Zhang X; Gallazzi F; Fernandez M; Moreno M; Gambini JP; Porcal W; Cabral P; Quinn TP
    Anticancer Agents Med Chem; 2015; 15(1):122-30. PubMed ID: 25175799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
    Guo H; Miao Y
    J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging.
    Guo H; Gallazzi F; Miao Y
    Mol Pharm; 2013 Apr; 10(4):1400-8. PubMed ID: 23418722
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Masteri Farahani A; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Chem Biol Drug Des; 2020 Aug; 96(2):850-860. PubMed ID: 32279449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary application of micro-SPECT/CT imaging by
    Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H
    Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of A Hexanoic Acid Linker Insertion on the Pharmacokinetics and Tumor Targeting Properties of the Melanoma Imaging Agent 99mTc-HYNIC-cycMSH.
    Teixeira V; Fernández M; Oddone N; Zhang X; Gallazzi F; Cerecetto H; Gambini JP; Porcal W; Cabral P; Quinn TP
    Anticancer Agents Med Chem; 2017; 17(8):1144-1152. PubMed ID: 27924732
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
    J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a (99m)Tc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors.
    Shamshirian D; Erfani M; Beiki D; Fallahi B; Shafiei M
    Ann Nucl Med; 2015 Oct; 29(8):709-20. PubMed ID: 26152564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved
    Khodadust F; Ahmadpour S; Aligholikhamseh N; Abedi SM; Hosseinimehr SJ
    Eur J Med Chem; 2018 Jan; 144():767-773. PubMed ID: 29291444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of a
    Torabizadeh SA; Abedi SM; Noaparast Z; Hosseinimehr SJ
    Bioorg Med Chem; 2017 May; 25(9):2583-2592. PubMed ID: 28351606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging human melanoma using a novel Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptide.
    Liu L; Xu J; Yang J; Feng C; Miao Y
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4724-4728. PubMed ID: 27568083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
    Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY
    J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic melanoma imaging using a novel Tc-99m-labeled lactam-cyclized alpha-MSH peptide.
    Liu L; Xu J; Yang J; Feng C; Miao Y
    Bioorg Med Chem Lett; 2017 Nov; 27(22):4952-4955. PubMed ID: 29054361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.
    Su ZF; He J; Rusckowski M; Hnatowich DJ
    Nucl Med Biol; 2003 Feb; 30(2):141-9. PubMed ID: 12623113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties.
    Raposinho PD; Xavier C; Correia JD; Falcão S; Gomes P; Santos I
    J Biol Inorg Chem; 2008 Mar; 13(3):449-59. PubMed ID: 18183429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel [
    Qiao Z; Xu J; Gonzalez R; Miao Y
    Mol Pharm; 2020 Sep; 17(9):3581-3588. PubMed ID: 32663011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphine-containing HYNIC derivatives as potential bifunctional chelators for (99m)Tc-labeling of small biomolecules.
    Purohit A; Liu S; Casebier D; Edwards DS
    Bioconjug Chem; 2003; 14(4):720-7. PubMed ID: 12862424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
    Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
    Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.